NCT02085993 Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training Status COMPLETED Phase N/A
NCT02072863 A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02066805 Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark Status COMPLETED Phase N/A
NCT02066415 A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention Status COMPLETED Phase PHASE2
NCT02054572 Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis Status COMPLETED Phase PHASE1
NCT02054130 Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma Status COMPLETED Phase PHASE2
NCT02053753 Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug Product Status COMPLETED Phase PHASE1
NCT02052882 Study of Romiplostim for Chemotherapy Induced Thrombocytopenia Status COMPLETED Phase PHASE2
NCT02047253 Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment Status COMPLETED Phase PHASE2
NCT02023866 Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease Status COMPLETED Phase PHASE2
NCT02016716 A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE3
NCT02016534 Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors Status TERMINATED Phase PHASE2
NCT02014441 Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec Status COMPLETED Phase PHASE2
NCT02013167 Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE3
NCT02010931 Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients Status COMPLETED Phase N/A
NCT02009345 Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada Status RECRUITING Phase N/A
NCT02003612 Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT02000427 Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01999335 A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma Status TERMINATED Phase PHASE1